Post-transplant factor | Entire cohort (n = 254) | Non-SSI (n = 244) | SSI (n = 10) | P value† |
---|---|---|---|---|
DGF | ||||
Without DGF, n, % | 138 (54.5%) | 133 (54.7%) | 5 (50.0%) | > .999 |
With DGF, n, % | 115 (45.5%) | 110 (45.3%) | 5 (50.0%) | |
PNF | ||||
Without PNF, n, % | 252 (99.6%) | 242 (99.6%) | 10 (100%) | > .999 |
With PNF, n, % | 1 (0.4%) | 1 (0.4%) | 0 (0.0%) | |
Lymphocele | ||||
No lymphocele, n, % | 192 (96.5%) | 184 (96.8%) | 8 (88.9%) | .280 |
With lymphocele, n, % | 7 (3.5%) | 6 (3.2%) | 1 (11.1%) | |
Hematoma | ||||
Without hematoma, n, % | 145 (73.2%) | 152 (75.1%) | 3 (33.3%) | .012 |
With hematoma, n, % | 53 (26.8%) | 47 (24.9%) | 6 (66.7%) | |
Need for reoperation at early follow-up | ||||
Reoperated, n, % | 29 (11.4%) | 24 (9.8%) | 5 (50.0%) | .002 |
Non-reoperated, n, % | 225 (88.6%) | 220 (90.2%) | 5 (50.0%) | |
UTI | ||||
Without UTI, n, % | 156 (61.4%) | 152 (52.3%) | 4 (40.0%) | .139 |
With UTI, n, % | 98 (38.6%) | 92 (37.7%) | 6 (60.0%) | |
Serum creatinine on the 30th POD | 1.64 [0.51–8.49] | 1.63 [0.51–8.49] | 2.06 [0.89–5.44] | .319 |
Serum creatinine on the 90th POD | 1.49 [0.64–8.30] | 1.49 [0.64–8.30] | 1.77 [1.01–7.99] | .162 |
Serum creatinine on the 180th POD | 1.48 [0.67–7.59] | 1.47 [0.67–7.59] | 1.76 [0.99–3.34] | .445 |
Serum creatinine on the 360th POD | 1.46 [0.71–6.00] | 1.44 [0.71–6.00] | 1.70 [0.96–3.26] | .355 |
Kidney function 1 year after transplantation | ||||
Graft survival less than 1 year, n, % | 10 (4.9%) | 8 (4.1%) | 2 (22.2%) | .064 |
Graft survived 1 year, n, % | 196 (95.1%) | 189 (95.9%) | 7 (77.8%) | |
MDRD on the 30th POD | 43.1 [7.34–142.00] | 43.1 [7.34–142.00] | 36.8 [8.73–106.00] | .387 |
MDRD on the 90th POD | 48.8 [6.89–109] | 49.0 [6.89–109.00] | 41.8 [7.14–80.60] | .230 |
MDRD on the 180th POD | 49.9 [8.17–122.00] | 50.0 [8.17–122.00] | 48.2 [23.50–78.80] | .684 |
MDRD on the 360th POD | 51.3 [7.92–141.00] | 51.5 [7.92–141.00] | 48.3 [24.20–85.50] | .481 |
Time of hospital stay, days | 7 [0–42] | 7 [0–38] | 7 [4–42] | .347 |